2013 Annual Report Revisedx6 12 24 14

Transcription

CANCERRegistry Annual Report 2013

EJGH Regional Cancer Center Renovation and Expansion Opening Summer 2014

Table of Contentspg. 4Very Good and Getting Betterpg. 6Introductionpg. 7Cancer Registry Activity Report, 2013pg. 8About East Jefferson General HospitalFacts on Cancer Cases, EJGH 2013pg. 10Evolution of Qualitypg. 11Comparison of East Jefferson General Hospital’s ExperienceAnd National Incidence Estimates of Top Sites, 2013pg. 12Site AnalysisSite Distribution of Newly Diagnosed Analytic Cases, 2011, 2012,2013; Site Distribution of Non-Analytic Cases, 2013pg. 17Colorectal Cancerpg. 23Lung Cancerpg. 29Breast Cancerpg. 33Prostate Cancerpg. 37Regional Cancer Center Program Componentspg. 39Other Cancer Program Componentspg. 46Acknowledgements3

I am proud to say I was involved from the start with our efforts to affiliatewith the University of Texas MD Anderson Cancer Center and have served in aleadership role from our initial affiliation in 2007 through today. That affiliationspeaks volumes to our community about our commitment to fighting cancer.The mission of MD Anderson is to eradicate cancer in Texas, the United Statesand the world. As a certified member of the MD Anderson Cancer Network, wejoin in that mission. It is more than a slogan; it is a mission we take veryseriously.Of course, for our patients, affiliation means peace of mind. They know theycan gain access to MD Anderson treatment protocols while remaining close tohome. For myself and my colleagues, affiliation means access to MD Anderson’sThomas Cosgriff, MDvast amount of research and innovation. We hold weekly calls with ourcolleagues in Houston to discuss specific cases and collaborate on plans ofVery Good and Getting Bettertreatment that are in the best interest of specific patients.That is how I would describe the work done by the Oncology Division at EastEvery day, I take inspiration from the patients I see and the wonderfullyJefferson General Hospital over the period of time covered by this report. Asdedicated physicians and other healthcare professionals with whom I work.Medical Director of Oncology, I have the privilege of working alongside a group ofWithin these pages you will see just how good we are in our fight against manycancer fighting physicians, nurses and professionals that I truly believe are asdifferent cancers. While I am proud of the numbers in this report, I am neverdedicated, talented, professional and effective as any group anywhere.satisfied with them. Nor are any of my colleagues, here or in Houston. We willcontinue working to be the finest regional cancer center anywhere, in LouisianaI have been practicing at East Jefferson General Hospital long enough to seeor the world.the field of oncology and our hospital’s oncology efforts change dramatically.Cancer treatment today is nothing like it was when I began my practice. WeSincerely,are not only better at fighting most types of cancers, our treatment processesare much more patient friendly. Yes, the treatments are still often harsh andgrueling, but almost always today’s treatment is easier on the patient than itwas only a few years before. And we continue improving in this area.4Thomas Cosgriff, MDMedical Director of Oncology Service and Oncology Committee ChairmanEast Jefferson General Hospital

5

The Cancer Registry was established with a reference date of January 1, 1988.East Jefferson General Hospital’s Cancer Program is approved by theCommission on Cancer of the American College of Surgeons since 1991. In2013 the Cancer Program was awarded three-year approval. Approvalindicates that the organization offers a broad-based network of comprehensivecancer programs that encompasses the entire spectrum of cancer controlactivities, from prevention to rehabilitation and long term follow-up.This report is prepared by the Cancer Registrar, an integral part of thehospital’s cancer program.Paul Monsour, M.D.Paul Monsour, MDIntroductionThe Regional Cancer Center at East Jefferson General Hospital is dedicated toMedical Director of Radiation TherapySiddhartha Padmanabha, M.D.Annual Report Advisorimproving the care of patients with cancer and ultimately reducing cancermortality. The accomplishments of each calendar year are summarized in theCancer Registry Annual Report. A statistical review of the calendar year isincluded along with an in-depth review of four major sites of cancer. Thepurpose of the report is to measure progress toward our goals and to educateEast Jefferson General Hospital physicians and other health care professionals.The four sites featured in this report are colorectal, lung, breast andprostate. These four sites account for 53.7 percent of the newly diagnosedcancers at East Jefferson General Hospital in 2013. Information on these andall other sites of cancer are available upon request.6Mary Beth Lobrano, M.D.Annual Report AdvisorMattie J. Hobley, MN, MS, NE-BCSenior Director Oncology ServicesReunda Gonsoulin, CTRCancer Registry Coordinator

Cancer Registry Activity Report, 2013Quality control was done on the Cancer Registry data by a member of theOncology Committee on at least 10 percent of the analytic cases.East Jefferson General Hospital’s Cancer Registry was established in 1988 tocollect and maintain a computerized database of all patients with adiagnosis of cancer and to conduct lifetime follow up. This provides theSite Specific Physician Championsmeans for monitoring and evaluating the success of the cancer program.Nothing great is accomplished without clear vision and leadership. ThroughoutThe Cancer Registry has entered a total of 34,452 cases; 29,662 are analytic (firstthe year, our organization was fortunate to have had physician champions whodiagnosed and/or received all or part of first course treatment at EJGH); 4,790 areguided us through a tremendous year of clinical progress.non-analytic (first seen at EJGH after completion of a full course of therapy atanother facility, coming to EJGH for recurrence and/or subsequent treatment).Brian Creely, MD – Breast Cancer Physician ChampionMichael Brothers, MD – Lung Cancer Physician ChampionIn 2013, the Cancer Registry accessioned 1,444 cases. Twelve hundred and ninetyJeffery Griffin, MD – Colorectal Cancer Physician Championtwo were analytic, and 152 were non-analytic. Annual follow up was conducted inSean Collins, MD – Prostate Cancer Physician Championall cases with a 91.27 percent follow-up rate for all analytic cases and 90.94percent follow-up rate for the last five years meeting the standard of theCommission on Cancer. The Cancer Registry participates in the National CancerData Base (NCDB) call for data annually. Hospital data is also reported to theLouisiana Cancer Registry annually.Forty-eight tumor boards were held in 2013, with 175 malignant casesbeing discussed, representing 13.5 percent of the analytic cases. NineteenBreast conferences were held in 2013.Twenty-eight MD Anderson Multidisciplinary Planning Video conferences wereheld in 2013 with discussion of AJCC stage and treatment guidelines on allmajor sites along with seven Continuing Medical Education lectures. Continuingeducation hours are approved for these activities.7

office buildings, three multilevel parking garages, an outpatient pavilion andthe Yenni Treatment Center. The campus also has a helipad, which canaccommodate most sizes of helicopters currently in use.Thanks to the dedication, loyalty and expertise of all our team members, bothpast and present, East Jefferson General Hospital continues to enjoy areputation second to none.Facts on Cancer atEast Jefferson General Hospital, 2013About East Jefferson General HospitalOpened on February 14, 1971, East Jefferson General Hospital is a publiclyowned 444-bed not-for-profit community hospital, providing tertiary care toresidents of the East Bank of Jefferson Parish and surrounding communities. Aservice district hospital, East Jefferson General is governed by a 10-membervolunteer Board of Directors appointed by the Jefferson Parish Council and theParish President.East Jefferson General is accredited by The Joint Commission Organization and hasbeen recognized as Louisiana’s first Magnet hospital by the American NursesCredentialing Center (ANCC). The 3,500 team members, 650 physicians and 400volunteers help bring the campus to life. The hospital campus features the mainhospital, East Jefferson North, four medical8Class of CasesNo. of CasesAnalytic Cases1,292Non-Analytic CasesTotal Number of Cases1521,444

9

There is a great amount of pride at East Jefferson General Hospital in our successes in cancer care. What makes it even more special isthat our physicians, nurses and outstanding clinicians view each success as a steppingstone to the next success. They are continuouslyseeking ways to deliver more effective, efficient andcompassionate care.This process of self-improvement is a hallmark of thestaff that considers it our evolution of quality. We usedata and dashboard metrics to be the foundation ofimprovement. We have a Quality Council andOncology Committee involving dedicated medicalexperts of the most important disciplines to offer aguiding voice. And, under the leadership of ourOncology Medical Director, Dr. Thomas Cosgriff, ourevolution will continue.Mattie Hobley, MN, MS, RN, NE-BCEvolution of QualityIn this report, you will see the result of our efforts. Itwill be found in the many numbers and charts.However, every day we come to work we remember that each number is a life. So at the center of everything we do, we know thatfamilies throughout our community counts on us to improve each day.Mattie Hobley, MN, MS, RN, NE-BCSenior Director of Oncology Services10

Cancer Program Practice Profile Reports (CP3R): for Breast,Colon and Rectal Cancers 2006 - 2011 DiagnosesEstimated Performance RatesSelect Breast & Colorectal MeasuresGOALRadiation therapy is administered within 1 year (365 days) of diagnosis for 2010201197%96.9%91.7%92.3%100%93.8%90.7%under age 70 receiving breast conserving surgery for breast cancer. [BCS/RT]BREASTCombination chemotherapy is considered or administered within 4 months (120 days) of93.3%diagnosis for women under 70 with AJCC T1c N0 M0, or Stage II or III ERA and PRAnegative breast cancer. [MAC]Tamoxifen or third generation aromatase inhibitor is considered or administered within90%85.4%86%84.7%92.5%92.4%1 year (365 days) of diagnosis for women with AJCC T1c N0 M0, or Stage II or III ERAand/or PRA positive breast cancer. [HT]Adjuvant chemotherapy is considered or administered within 4 months (120 days) ofCdiagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive)Ocolon cancer. .5%93.6%93.6%86.8%90%75%100%100%100%100%100%LOAt least 12 regional lymph nodes are removed and pathologically examined forNresected colon cancer. [12RLN]RECRadiation therapy is considered or administered within 6 months (180 days) of diagnosisfor patients under the age of 80 with clinical or pathologic AJCC T4N0M0 or Stage IIIreceiving surgical resection for rectal cancer. [AdjRT]Background: The National Quality Forum (NQF) brought public and private payers together with consumers, researchers and clinicians to broaden consensus on performance measures for breast and colorectalcancer. The performance rates shown in the Cancer Program Practice Profile Reports (CP3R) match the specifications of the breast, colon and rectal cancer care measures endorsed by the NQF in April, 2007. TheCommission on Cancer has been actively engaged in this process. The CoC has instituted the CP3R as a facility feedback mechanism to promote awareness of the importance of charting and coding accuracy in linewith evidence based practice guidelines. In light of the national movement towards Pay for Performance (P4P), these reports provide CoC-Approved programs with the ability to examine program-specific breast, colonand rectal cancer care practices.This page and all contents are Copyright 2012 by the NCDB and American College of Surgeons, Chicago, IL 60611-321111

Ranked Market Leader for Patient Safety in Hospital Overall Careby CareChex, a Division of COMPARION2012 - 201311

East Jefferson General Hospital Incidence Compared toNational Incidence Estimates of Top Sites, 2013*MaleFemalePercentages of 14%--34%30%9%9%Colorectal8%9%8%6%Urinary Bladder--6%7%Leukemia/Lymphoma4%4%4%3%Oral Cavity--3%5%Malignant Melanoma2%4%2%3%Pancreas2%3%--Female Genital6%7%8%5%Kidney & Renal Pelvis4%3%20%20%All Other24%26%BreastAt East Jefferson General Hospital in 2013: Female Breast cancers are 4 percent higher at EJGH than nationally. Female Lung cancers at EJGH are 2 percent higher than nationally.*Represents estimates of numbers, Cancer Facts & Figures, American Cancer Society, 201312Percentages of CasesUSA*

Site Distribution of Newly Diagnosed Analytic Cases, 2011, 2012, 20132011Lip, Oral Cavity & Pharynx222012(1.7%)262013(2.0%)36 (2.8%)Lip---Tongue101113Major Salivary Gland216Floor of onsil--6Gum & Other Parts of Mouth395241 (16.3%)184 (14.2%)Digestive SystemEsophagus228 bladder223Other Bile Duct122Pancreas282830Anus, Anal Canal and Anorectum-73StomachSmall IntestineRespiratory, Intrathoracic202 (14.2%)202 (15.5%)110212 (16.4%)Nose, Nasal Cavity & Middle Ear-21Larynx21412Lung200186Heart, Mediastinum & Pleura7 (0.6%)7 (0.5%)19916 (1.2%)13

14201120122013Hematopoietic & Lymphatic88 (6.9%)108 (8.3%)98 (7.6%)Leukemia141921Multiple Myeloma9819Hodgkin’s Disease9129Non-Hodgkin’s Lymphoma525749Myeloproliferative Disorder412-Bone & Soft Tissue8 (0.6%)7 (0.6%)2 (0.2%)Bone---Soft Tissue872Skin21 (1.6%)28 (2.2%)34 (2.6%)Malignant Melanoma192724Other Skin2110Breast293 (22.7%)252 (19.4%)228(17.6%)Female292249226Male132Female Genital Organs39 (3.0%)51 (3.9%)43 (3.3%)Cervix584Ovary & Fallopian Tube151912Corpus Uteri191925Vagina/Vulva-52

201120122013Male Genital Organs170 (13.2%)195 (15.0%)174 (13.5%)Prostate164190164Testis548Penis112Urinary Tract124 (9.6%)138 (10.6%)152 (11.8%)Bladder576278Kidney617173Ureter55-Other Urinary1-1Eye & Orbit1 (0.1%)1 (0.6%)0 (0.0%)Brain & Nervous System16 (1.2%)29 (2.3%)40 (3.1%)Brain111418Meninges & Cranial Nerves51522Endocrine Glands24 (1.9%)32 (2.4%)31 (2.4%)Thyroid243129Other Endocrine-12Unknown36 (2.8%)28 (1.8%)51 (14.0%)Total1,2891,2991,29215

Site Distribution of Non-Analytic Cases, 201316Oral Cavity & Pharynx3 (2.0%)Digestive Organs18 (11.9 %)Respiratory and Intrathoracic System14 (9.3%)Hematopoietic/Lymphatic14 (9.3%)Skin4 (2.6%)Breast18 (11.9%)Female Genital Organs14 (9.3%)Male Genital Organs39 (25.8%)Urinary System16 (10.6%)Brain/Meninges2 (1.3%)Other9 (6.0%)Total151

Colon & Rectum CancerColorectal cancer was the fourth most common cancer reported at East Jefferson General Hospital in 2013 with 111 analytic cases compared to 228 breast cases,190 lung cases and 164 prostate cases.The patient population included 58 males representing 5.8 percent of male cancer cases and 53 females representing 8.1 percent of female cancer cases.Seven cases (5.8%) were Stage 0 (in situ), 22 (18.2%) cases Stage I (Dukes A), 22 (18.2%) were Stage II (Dukes B), 38 (31.4%) were Stage III (Dukes C), 22(18.2%) were Stage IV and 10 (8.2%) were unknown stage.Age atDiagnosisNo. ofPatientsSub-sitesNo. ofPatientsCecum21 (18.9%)1 (10.9%)Ascending22 (19.8%)40-498 (7.2%)Transverse*9 (8.1%)50-5924 (21.6%)Descending10 (9.1%)60-6923 (20.7%)Sigmoid**22 (19.8%)23 (20.7%)30-3970-7932 (28.9%)Rectum80-8916 (14.4%)Colorectal NOS4 (3.6%)90 7 (6.3%)Total111Total111*Transverse includes hepatic and splenic flexure**Sigmoid includes recto-sigmoid*** NOS not otherwise specific17

Colon Five-Year Survival by AJCC Stage EJGH (diagnosed 2003-2007)StageCasesAt diag.1 yr2 yr3 yr4 yr5 .5IV6510052.329.216.913.810.818

Colon by Treatment Combinations EJGH 20ChemoSurgSurg/RadsSurg/ChemoOther

Rectum Five-Year Survival by AJCC Stage EJGH (diagnosed 2003-2007)StageCasesAt diag.1 yr2 yr3 yr4 yr5 V3410067.242.235.722.114.720

Rectum by Treatment Combinations EJGH ds/ChemoSurg/Rads/ChemoSurgSurg/ChemoOther20

Lung CancerLung cancer was the second most common cancer at East Jefferson General Hospital in 2013, with 190 analytic cases. The patient population includes 81 malesrepresenting 14 percent of the male cancer cases and 109 females representing 16 percent of the female cancer cases.Eleven cases were small-cell lung cancer (SCLC) cases, representing 7 percent of the lung cancers with 176 non-small cancers (NSCLC), representing 93 percentof the lung cancer cases.Age At22DiagnosisNon-Small Cell30-390 (0.0%)Small Cell40-496 (3.4%)0 (7.7%)50-5922 (13.0 %)1 (7.7%)60-6962 (35.0%)3 (23.1%)70-7957 (32.2%)7 (53.8%)80-8924 (13.6%)0 (0.0%)90 5 (2.8%)0 (0.0%)Total17611

Small Cell Lung Cancer Five-Year Survival by AJCC Stage EJGH (diagnosed 2003-2007)StageCasesAt diag.1 yr2 yr3 yr4 yr5 10.7111

Small Cell Lung Cancer by Treatment Combinations EJGH, ds/Chemo/PallUnk/None

Non-Small Cell Lung Five-Year Survival by AJCC Stage EJGH (diagnosed 20032007)24StageCasesAt diag.1 yr2 yr3 yr4 yr5 51IV19710031.011.51.01.01.025

Non-Small Cell Lung Cancer (NSCLC) By Treatment Combinations EJGH k/none

Breast CancerBreast was the most common site of cancer in females treated at East Jefferson General Hospital in 2013 with 228 analytic cases representing31.3 percent of the female cancer cases. Two of the cases were male breast. 12.3 percent of the cases were under the age of 50 at the time ofdiagnosis.Forty cases (17.6%) were Stage 0, 90 (39.5%) were Stage I, 58 (25.4%) were Stage II, 27 (11.8%) were Stage III, and 11 (4.8%) were StageIV, 2 (0.9%) were of unknown stage.Age at Diagnosis29No. Of Patients0-2930-3940-4950-5960-6970-7980 2%)(22.4%)(9.2%)

Breast Five-Year Survival by AJCC Stage EJGH (diagnosed 2003-2007)StageCasesAt diag.1 yr2 yr3 yr4 yr5 382.581.775.0IV4110053.739.031.722.017.1

Breast Treatment Combinations by AJCC Stage EJGH own5030

Prostate CancerAt East Jefferson General Hospital prostate cancer was the most common cancer inmales in 2013 with 164 analytic cases representing 26 percent of the male cancercases compared to 81 men with lung primaries representing 12.8 percent of themale cancer cases.Twenty-six cases were Stage I (15.9%), 107 were Stage II (65.2%), 15 cases wereStage III (9.1%), 16 cases were Stage IV (9.8%); there were 0 cases with unknownStage (0.0%)Sean Collins, MD“One of the prime examples of East Jefferson General Hospital’sAge at Diagnosis EJGHcommitment to the latest technology and cutting-edge procedures is found40-493 (1.8%)in our Robotics Department. Using the da Vinci Robotic Surgical System,50-5932 (19.5%)60-6960 (36.6%)70-7952 (31.7%)80-8916 (9.8%)90 1 (0.6%)Total164we are more effectively treating cancers and other conditions. Weunderstand that these types of innovat

the Yenni Treatment Center. The campus also has a helipad, which can accommodate most sizes of helicopters currently in use. Thanks to the dedication, loyalty and expertise of all our team members, both past and present, East Jefferson General Hospital continues